For over three decades, Liu Li Ping has been racing against stroke. She led the landmark “CHANCE” clinical trial—the first from China published in The New England Journal of Medicine—reducing patients’ 90-day recurrence rate from 11.7% to 8.2%, and further down to 6% in subsequent studies, rewriting global treatment guidelines and saving millions of lives. Her team developed domestically produced thrombolytic drugs, ending reliance on expensive imports, and combined them with AI imaging systems to cut treatment times from 120 minutes to just 20, extending the treatment window from 4.5 hours to 24. For Liu, victory in medicine is never a finish line—it is the courage to leave the comfort zone, to move from saving one life to transforming an entire field, and to keep going where the road runs long. Chief Scientist, Neurology Center, Beijing Tiantan Hospital This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at https://www.ted.com/tedx